• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cost-Effectiveness Of Apixaban Compared To Other Anticoagulants For Lifetime Treatment And Prevention Of Recurrent Venous Thromboembolism.

作者信息

Lanitis T, Hamilton M, Rublee D A, Leipold R, Quon P, Browne C, Cohen A T

机构信息

Evidera, London, UK.

Bristol-Myers Squibb Company, Princeton, NJ, USA.

出版信息

Value Health. 2014 Nov;17(7):A488. doi: 10.1016/j.jval.2014.08.1434. Epub 2014 Oct 26.

DOI:10.1016/j.jval.2014.08.1434
PMID:27201443
Abstract
摘要

相似文献

1
Cost-Effectiveness Of Apixaban Compared To Other Anticoagulants For Lifetime Treatment And Prevention Of Recurrent Venous Thromboembolism.阿哌沙班与其他抗凝剂相比用于终身治疗和预防复发性静脉血栓栓塞的成本效益
Value Health. 2014 Nov;17(7):A488. doi: 10.1016/j.jval.2014.08.1434. Epub 2014 Oct 26.
2
A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.一项比较阿哌沙班与依诺肝素用于术后静脉血栓栓塞预防的成本效益的加拿大研究。
Postgrad Med. 2013 Jul;125(4):141-53. doi: 10.3810/pgm.2013.07.2686.
3
Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.阿哌沙班与其他新型口服抗凝药预防心房颤动卒中的成本效益比较。
Clin Ther. 2014 Feb 1;36(2):192-210.e20. doi: 10.1016/j.clinthera.2013.12.011. Epub 2014 Feb 6.
4
[Cost-effectiveness analysis of apixaban compared to dabigatran in the prevention of venous thromboembolism in patients subjected to total knee or hip replacement].阿哌沙班与达比加群在全膝关节或全髋关节置换患者预防静脉血栓栓塞方面的成本效益分析
Rev Esp Cir Ortop Traumatol. 2012 Nov-Dec;56(6):459-70. doi: 10.1016/j.recot.2012.07.009. Epub 2012 Sep 7.
5
[From apixaban to aspirin in the prevention of recurrent venous thromboembolism].
Invest Clin. 2013 Sep;54(3):231-3.
6
Oral apixaban for the treatment of acute venous thromboembolism.口服阿哌沙班治疗急性静脉血栓栓塞症。
N Engl J Med. 2013 Aug 29;369(9):799-808. doi: 10.1056/NEJMoa1302507. Epub 2013 Jul 1.
7
Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin.法国心房颤动患者的卒中预防：新型口服抗凝剂（阿哌沙班、达比加群和利伐沙班）、华法林和阿司匹林的成本效果比较。
J Med Econ. 2014 Aug;17(8):587-98. doi: 10.3111/13696998.2014.923891. Epub 2014 May 29.
8
Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.达比加群、利伐沙班和阿哌沙班用于延长静脉血栓栓塞症治疗：网状Meta分析。
Int Angiol. 2014 Aug;33(4):301-8.
9
Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: a U.S. perspective.利伐沙班与华法林抗凝预防复发性静脉血栓栓塞的成本效益：美国视角。
Thromb Res. 2013;132(6):647-51. doi: 10.1016/j.thromres.2013.09.015. Epub 2013 Sep 20.
10
Aspirin for prevention and treatment of venous thromboembolism.阿司匹林用于预防和治疗静脉血栓栓塞症。
Blood Rev. 2014 May;28(3):103-8. doi: 10.1016/j.blre.2014.03.003. Epub 2014 Apr 1.

引用本文的文献

1
Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects.阿哌沙班在荷兰预防静脉血栓栓塞的延长治疗：临床和经济效果
TH Open. 2018 Sep 26;2(3):e315-e324. doi: 10.1055/s-0038-1672185. eCollection 2018 Jul.
2
Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep-Vein Thrombosis as First-Line Therapy (AMPLIFY) Trial.阿哌沙班可减少静脉血栓栓塞患者的住院率：阿哌沙班用于肺栓塞和深静脉血栓形成初始治疗作为一线疗法的分析（AMPLIFY）试验
J Am Heart Assoc. 2015 Dec 1;4(12):e002340. doi: 10.1161/JAHA.115.002340.